| Name | Title | Contact Details |
|---|---|---|
Ryan Johnsen |
Chief Technology Officer | Profile |
Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating cytokine storm via its novel, cutting-edge anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody neutralizati.
ChemBridge Corporation is a privately held US company founded in Chicago in 1993 and relocated to San Diego in 1997. ChemBridge has European offices in the UK, a marketing agency in Japan, and operates a large, state-of-the-art offshore chemistry
SSCI is a West Lafayette, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HumanCo is a mission-driven private holding company that invests in and builds brands focused on healthier living and sustainability.
New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods.